Back to HomeBeta

ICD-10 Coding for Neuroendocrine Tumors(C7A.01, C7A.1)

Complete ICD-10-CM coding and documentation guide for Neuroendocrine Tumors. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

NETsCarcinoid Tumors

Related ICD-10 Code Ranges

Complete code families applicable to Neuroendocrine Tumors

C7APrimary Range

Malignant neuroendocrine tumors

Primary range for coding malignant neuroendocrine tumors, including specific sites and differentiation.

Benign neuroendocrine tumors

Used for coding benign neuroendocrine tumors when behavior is confirmed as non-malignant.

Secondary neuroendocrine tumors

Used for coding metastatic sites of neuroendocrine tumors.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C7A.01Malignant carcinoid tumor of the small intestineUse when a malignant carcinoid tumor is confirmed in the small intestine.
  • Histological confirmation of malignancy
  • Documentation of specific small intestine site
C7A.1Poorly differentiated neuroendocrine tumorsUse when a neuroendocrine tumor is poorly differentiated.
  • Documentation of poor differentiation
  • Ki-67 index ≥20%

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for neuroendocrine tumors

Essential facts and insights about Neuroendocrine Tumors

The ICD-10 code for malignant neuroendocrine tumors is C7A, with specific subcodes for different sites and differentiation levels.

Primary ICD-10-CM Codes for neuroendocrine tumours

Malignant carcinoid tumor of the small intestine
Non-billable Code

Decision Criteria

clinical Criteria

  • Histological confirmation of malignancy

documentation Criteria

  • Specific site within the small intestine

Applicable To

  • Malignant carcinoid of duodenum
  • Malignant carcinoid of jejunum

Excludes

  • Benign carcinoid tumor (D3A.0)

Clinical Validation Requirements

  • Histological confirmation of malignancy
  • Documentation of specific small intestine site

Code-Specific Risks

  • Misclassification as benign if documentation is unclear

Coding Notes

  • Ensure documentation specifies malignancy and site for accurate coding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Carcinoid syndrome

E34.0
Use when symptoms of carcinoid syndrome are documented.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Benign carcinoid tumor

D3A.0
Use D3A.0 if the tumor is confirmed as benign.

Well-differentiated neuroendocrine tumors

C7A.0
Use C7A.0 for well-differentiated tumors with lower Ki-67 index.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Neuroendocrine Tumors to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C7A.01.

Impact

Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for incorrect coding and billing.

Mitigation Strategy

Ensure pathology reports include grade, Train staff on documentation standards

Impact

Reimbursement: Incorrect coding can lead to inappropriate DRG assignment., Compliance: May result in non-compliance with coding guidelines., Data Quality: Affects the accuracy of clinical data.

Mitigation Strategy

Always refer to the alphabetic index for neuroendocrine tumors.

Impact

Incomplete documentation of tumor differentiation and grade.

Mitigation Strategy

Implement regular audits and training sessions.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Neuroendocrine Tumors, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Neuroendocrine Tumors

Use these documentation templates to ensure complete and accurate documentation for Neuroendocrine Tumors. These templates include all required elements for proper coding and billing.

Progress Note for NET

Specialty: Oncology

Required Elements

  • Tumor location
  • Size
  • Grade
  • Imaging results
  • Lab findings

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient with NET. Plan: Follow-up.
Good Documentation Example
68M with well-differentiated neuroendocrine tumor (G1) of pancreatic head, 2.3 cm, Ki-67 3%, no angioinvasion. SSR-PET shows no distant metastases. Plan: Surveillance imaging in 6 months.
Explanation
The good example provides specific details about the tumor's characteristics and planned management.

Need help with ICD-10 coding for Neuroendocrine Tumors? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more